Recent trends in bacteriological and antibiogram profile of isolates from ear, nose and throat in a tertiary care hospital in coastal Karnataka
<p class="abstract"><strong>Background:</strong> The objectives were to study the bacterial pathogens of ear, nose and throat (ENT), to determine the culture and sensitivity pattern of ENT infections in coastal Karnataka.</p><p class="abstract"><strong>Methods:</strong> A retrospective culture and sensitivity profiling study of 109 samples from September 2018 to September 2019 was done in Department of ENT in KVG Medical College and Hospital. </p><p class="abstract"><strong>Results:</strong> Among the pure growth, <em>Pseudomonas aeruginosa</em> was isolated in majority of samples (27.77%) followed by <em>Staphylococcus aureus</em> (22.9%). <em>Klebsiella </em>sp<em>.,</em> <em>Acinetobacter </em>sp., <em>Citrobacter</em>, <em>Non enterococcus</em>, <em>Escherichia coli</em>, <em>Proteus </em>sp. and <em>Streptococcus pneumoniae</em> were responsible for remaining samples. Among <em>S. aureus</em> majority was MRSA accounting for 18.51%. <em>P. aeruginosa</em> was most sensitive to amikacin, ceftazidime, meropenem and piperacillin- tazobactam and least sensitive to cotrimoxazole and colistin and most resistant to sparfloxacin, cefaperazone-sulbactam, ceftriaxone-tazobactam and clindamycin. MRSA was most sensitive to gentamicin, amikacin and clindamycin and most resistant to cephalexin, ampicillin and ciprofloxacin. <em>Klebsiella </em>sp<em>.</em> was most sensitive to amikacin and cotrimoxazole and most resistant to sparfloxacin and ceftriaxone<em>. E. coli</em> was most sensitive to gentamicin and cotrimoxazole and most resistant to sparfloxacin.</p><p><strong>Conclusions:</strong> <em>P. aeruginosa, S. aureus</em> and <em>Klebsiella </em>sp<em>. </em>represent majority of culture samples. With ever changing culture & sensitivity pattern and rising antibiotic resistance, a simple step of sending pus samples for the same will help in personalizing the treatment, thereby reducing the disease burden. </p>